Company / Capital Expenditures
Innoviva, Inc. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$1.1M
FY2025
5-year range
$0 / $1.1M
FY2021-FY2025
Trend
+318.9%
vs FY2024
Sector context
#110 of 194
Health Care
What the data says
Capital Expenditures changed +319% YoY in FY2025, a notable deviation from the 6-year average annual change of +508%.
Based on SEC 10-K filings.
$1M in FY2025 with a 5-year CAGR of +144.3%.
Improved from $411,000 to $1M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +343.1%
- 5-Year CAGR
- +144.3%
- 10-Year CAGR
- -
Sector benchmark
#110 of 194 in Health CareTop 57% of 194This company $1.1M Sector average $117.5M
▼
-99.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +144.3%, indicating consistent growth.
- In FY2025, capital expenditures increased 318.9% year-over-year.
- Ranks #110 out of 194 companies in the Health Care sector.
- Lowest capital expenditures in the period was in FY2021.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1M | +318.9% |
| FY2024 | $270.0K | -34.3% |
| FY2023 | $411.0K | +3061.5% |
| FY2022 | $13.0K | - |
| FY2021 | $0 | -100.0% |
| FY2020 | $13.0K | - |
| FY2019 | $0 | -100.0% |
| FY2018 | $278.0K | - |
| FY2017 | $0 | -100.0% |
| FY2016 | $278.0K | +3871.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026